MICROBOT MEDICAL INC. 10Q. I only bought into this the other day.
Financial Performance
Revenue: $105K — First-ever commercial revenue from the LIBERTY® Endovascular Robotic System.
Gross Profit: $2K (Cost of revenues $103K).
Net Loss: $(3.671)M vs. $(2.601)M in Q1 2025.
Loss per Share: $(0.05) (basic/diluted).
Balance Sheet & Liquidity
Cash & Cash Equivalents: $3.657M (\~$3.66M).
Marketable Securities: $68.843M (\~$68.84M).
Total Liquidity (cash + marketable securities, excluding restricted): ≈ $72.5M.
Strong runway — management believes sufficient for >12 months of operations.
Shares outstanding: 67,158,044 (as of Mar 31).
\*The summary was AI generated.